C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
11/2002
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479518 Zwitterionic tachykinin receptor antagonists
11/12/2002	US6479491 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists
11/07/2002	US20020165298 Amino- and hydroxysubstituted triphenyl-s-triazines as stabilizers
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165228 Antiproliferative agents; antidiabetic agents
11/07/2002	US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents
11/07/2002	US20020165096 Applying to weeds
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/05/2002	WO2001085673A1 Phenyl-substituted 2-enamino-keto nitriles
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	CA2408209A1 Phenyl-substituted 2-enamino-keto nitriles
10/2002
10/31/2002	WO2002086138A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
10/31/2002	WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002	WO2002085841A2 Substituted catechol derivatives derived from polybasic secondary amino acids, method for production and use thereof
10/31/2002	WO2002069895A3 Heterocyclic analgesic compounds and methods of use thereof
10/30/2002	EP1159254A4 Oxyalkylene-substituted aminophenol intermediate
10/30/2002	CN1377268A Cell adhesion inhibitors
10/29/2002	US6472529 Viricides
10/29/2002	US6472388 Psychotherapeutic agents.
10/29/2002	US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2000040247A9 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/24/2002	US20020156276 Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same
10/24/2002	US20020156070 Felbamate derived compounds
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002	US6469164 2-hydroxy group of 4-benzyl-2-hydroxy-1,4-oxazin-3-one is activated with 1-(3,5-bis(trifluoromethyl)-phenyl) ethan-1-ol in presence of lewis acid, crystallization of driven epimerization of anomeric center with a base
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002062301A3 Method and composition for rejuvinating cells, tissues, organs, hair and nails
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/15/2002	US6465644 Sulfonated [8,9] benzophenoxazine dyes and the use of their labelled conjugates
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	CA2264685C 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
10/10/2002	WO2002079178A1 Methods for producing oxirane carboxylic acids and derivatives thereof
10/10/2002	WO2002078744A1 Remedies for psychoneurosis
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	US20020147238 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen
10/10/2002	US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002	US20020147189 Immunology response; autoimmune disease
10/10/2002	US20020146453 For sustained release; therapy
10/10/2002	DE10117730A1 One-pot reaction of amines, useful for preparing e.g. cyclic secondary amines or alcohols, useful as pharmaceutical intermediates, by oxidation with lysine oxidase then reduction
10/10/2002	DE10115938A1 Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon Process for preparing oxirane carboxylic acids and derivatives thereof
10/10/2002	CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/09/2002	EP0964856B1 Bicyclic amino acids
10/08/2002	US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002	CA2108967C Arylmorpholine, preparation and use
10/03/2002	WO2002076462A1 Drugs for improving insulin resistance
10/03/2002	US20020143012 For imaging amyloid deposits
10/03/2002	US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002	US20020142993 Pharmaceutically acceptable salts of bicyclic compounds
10/03/2002	US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/02/2002	EP0679641B1 Sulfonamide and sulfonic ester derivatives each having tricyclic hetero ring
10/01/2002	US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002	US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002	US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002	CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists
09/2002
09/26/2002	WO2002074755A1 Method of producing n-substituted 2,6-dialkyl morpholines
09/26/2002	WO2002074735A2 Biurethane derivatives
09/26/2002	US20020137789 Anticancer agents
09/26/2002	US20020137068 Reagents for labeling biomolecules having aldehyde or ketone Moieties
09/26/2002	DE10113402A1 New N,N'-bis-(Aminocarbonyl)-hydrazine derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, apoplexy, restenosis or tumors
09/26/2002	CA2441427A1 Biurethane derivatives
09/25/2002	EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use
09/24/2002	US6455735 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent
09/24/2002	US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/19/2002	US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
09/19/2002	US20020132807 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
09/18/2002	CN1370070A Carnitine analogues as topical, microbicidal spermicides
09/17/2002	US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002	US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002	US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002	US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/12/2002	WO2002070726A1 Process for preparation of optically active propoxyaniline derivatives
09/12/2002	WO2002070541A2 Peptide deformylase inhibitors
09/12/2002	WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof
09/12/2002	WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002	WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy
09/12/2002	WO2002069994A2 Combined use of derivatives of glp-1 analogs and ppar ligands
09/12/2002	WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof
09/12/2002	WO2001012600A9 INHIBITORS OF FACTOR Xa
09/12/2002	US20020128260 Useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR); fused ring derivatives of malonic acid, ester or amides
09/12/2002	US20020127428 Organic light emitting displays and new fluorescent compounds
09/12/2002	US20020124326 Contacting the substrate with a mono-, di-, or trialkoxy-substituted perfluoroalkane, perfluorocycloalkane, or perfluorocycloalkyl(ene)- containing perfluoroalkane
09/12/2002	CA2440411A1 Process for preparation of optically active propoxyaniline derivatives
09/12/2002	CA2439849A1 Antagonists of mcp-1 function and methods of use thereof
09/12/2002	CA2439827A1 Peptide deformylase inhibitors
09/12/2002	CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/11/2002	EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
09/10/2002	US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002	US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors

1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 112